Definium Therapeutics, Inc. (DFTX)
16.23
-1.12
(-6.46%)
USD |
NASDAQ |
Feb 12, 16:00
16.23
0.00 (0.00%)
After-Hours: 06:20
Definium Therapeutics Total Assets (Quarterly) : 236.92M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pulse Biosciences, Inc. | 108.76M |
| RxSight, Inc. | 308.53M |
| Plus Therapeutics, Inc. | 18.67M |
| Viridian Therapeutics, Inc. | 577.14M |
| Nutriband, Inc. | 8.419M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 106.32M |
| Shareholders Equity (Quarterly) | 130.60M |
| Debt to Equity Ratio | 0.3092 |
| Current Ratio | 3.300 |
| Net Debt Paydown Yield | -0.36% |